...
首页> 外文期刊>Journal of Clinical Microbiology >Real-Time Nucleic Acid Sequence-Based Amplification Is More Convenient than Real-Time PCR for Quantification of Plasmodium falciparum
【24h】

Real-Time Nucleic Acid Sequence-Based Amplification Is More Convenient than Real-Time PCR for Quantification of Plasmodium falciparum

机译:基于实时核酸序列的扩增比实时PCR定量恶性疟原虫更方便

获取原文
           

摘要

Determination of the number of malaria parasites by routine or even expert microscopy is not always sufficiently sensitive for detailed quantitative studies on the population dynamics of Plasmodium falciparum, such as intervention or vaccine trials. To circumvent this problem, two more sensitive assays, real-time quantitative nucleic acid sequence-based amplification (QT-NASBA) and real-time quantitative PCR (QT-PCR) were compared for quantification of P. falciparum parasites. QT-NASBA was adapted to molecular beacon real-time detection technology, which enables a reduction of the time of analysis and of contamination risk while retaining the specificity and sensitivity of the original assay. Both QT-NASBA and QT-PCR have a sensitivity of 20 parasites/ml of blood, but QT-PCR requires a complicated DNA extraction procedure and the use of 500 μl of venous blood to achieve this sensitivity, compared to 50 μl of finger prick blood for real-time QT-NASBA. Both techniques show a significant correlation to microscopic parasite counts, and the quantification results of the two real-time assays are significantly correlated for in vitro as well as in vivo samples. However, in comparison to real-time QT-PCR, the results of real-time QT-NASBA can be obtained 12 h earlier, with relatively easy RNA extraction and use of finger prick blood samples. The prospective development of multiplex QT-NASBA for detection of various P. falciparum developmental stages increases the value of QT-NASBA for malaria studies. Therefore, for studies requiring sensitive and accurate detection of P. falciparum parasites in large numbers of samples, the use of real-time QT-NASBA is preferred over that of real-time QT-PCR.
机译:对于常规恶性疟原虫种群动态的详细定量研究(例如干预或疫苗试验),通过常规甚至专家显微镜确定疟原虫数量并不总是足够敏感。为了避免这个问题,比较了两种更灵敏的检测方法,即基于实时定量核酸序列的扩增(QT-NASBA)和实时定量PCR(QT-PCR)来定量 P。恶性疟原虫。 QT-NASBA适用于分子信标实时检测技术,该技术可减少分析时间和污染风险,同时保留原始分析的特异性和敏感性。 QT-NASBA和QT-PCR均具有20寄生虫/ ml血液的敏感性,但与50μl的手指刺相比,QT-PCR需要复杂的DNA提取程序并使用500μl的静脉血来达到此敏感性。实时QT-NASBA的血液。两种技术均显示与微观寄生虫计数显着相关,并且两种实时测定的定量结果对于体外和体内样品均显着相关。但是,与实时QT-PCR相比,实时QT-NASBA的结果可以提前12小时获得,并且相对容易提取RNA和使用手指刺血样品。用于检测各种 P的多重QT-NASBA的前瞻性开发。恶性疟原虫的发育阶段提高了QT-NASBA在疟疾研究中的价值。因此,对于需要灵敏,准确检测 P的研究。大量样品中存在恶性疟原虫,因此实时QT-NASBA的使用优于实时QT-PCR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号